Back to top
more

West Pharmaceutical Services (WST)

(Real Time Quote from BATS)

$325.94 USD

325.94
42,732

+11.17 (3.55%)

Updated Nov 5, 2024 10:28 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Luminex Expands COVID-19 Testing With New Antibody Test

by Zacks Equity Research

Luminex (LMNX) submits an EUA request to the FDA for its first multi-antigen IgG assay.

Sweta Killa headshot

5 Great Dividend Growth Stocks Amid Market Volatility

by Sweta Killa

The second wave of coronavirus infections has flared up volatility and made investors scurry for safety and regular income. This has resulted in higher appeal for dividend investing.

Here's Why You Should Hold on to CONMED (CNMD) Stock for Now

by Zacks Equity Research

CONMED (CNMD) continues to benefit from robust international sales, broad product portfolio and persistent focus on R&D. However, forex remains a woe.

Masimo's (MASI) New Offering to Improve Patient Outcomes

by Zacks Equity Research

Masimo's (MASI) Centroid gets FDA clearance and can help clinicians monitor patient position, thereby improving patient outcomes.

Ecolab's New Pest Elimination Service to Ensure Food Safety

by Zacks Equity Research

Ecolab's (ECL) introduces Rodent Ceiling Service, which can help reduce the risk to food safety and public health.

Masimo (MASI) Boosts Product Portfolio with New Solution

by Zacks Equity Research

Masimo (MASI) unveils Masimo Sleep to help consumers better understand their quality of sleep.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) continues to gain from solid prospects in EHR and strategic deals. However, intense competition remains a woe.

The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply

PerkinElmer's Tie-Up to Boost Health Outcomes in Africa

by Zacks Equity Research

PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.

Sweta Killa headshot

5 S&P 500 Winners of 100 Days of Coronavirus Pandemic

by Sweta Killa

Today marks 100 days since the World Health Organization declared COVID-19 a pandemic on Mar 11. We have highlighted some stocks from the S&P 500 index that soared more than 40% during this period.

Accuray's New CyberKnife S7 System to Boost Patient Care

by Zacks Equity Research

Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.

Tirthankar Chakraborty headshot

5 Best Stocks From 100 Days of Coronavirus

by Tirthankar Chakraborty

Here're five big stock winners from the first 100 days of the coronavirus pandemic that ravaged the global economy and shook the stock market.

Buy These 5 Low Leverage Stocks to Avoid Debt-Related Risk

by Zacks Equity Research

Exorbitant debt financing might even cause a corporation's bankruptcy in the worst-case scenario.

Here's Why You Should Hold on to Intuitive Surgical Stock Now

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.

AMN Healthcare (AMN) Introduces New Customizable Offering

by Zacks Equity Research

AMN Healthcare (AMN) offers a customizable return-to-work solutions as businesses resume operations amid the ongoing pandemic.

Here's Why You Should Add AngioDynamics to Your Portfolio

by Zacks Equity Research

AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.

HMS Holdings' Solution to Help Consumers Amid Coronavirus

by Zacks Equity Research

HMS Holdings (HMSY) offers a unique COVID-19 health management and communications solution to support consumers during the pandemic.

Sweta Killa headshot

Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?

by Sweta Killa

Smart Beta ETF report for JPME

DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe

by Zacks Equity Research

DexCom (DXCM) announces the receipt of CE Marking across Europe for its G6 CGM System.

Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge

by Zacks Equity Research

Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako, broad product portfolio and solid international growth. However, pricing pressure raises concern.

Top 3 Momentum Anomaly Stocks to Consider on Investor Optimism

by Zacks Equity Research

These frontrunners are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.

Here's Why You Should Retain NextGen Healthcare Stock Now

by Zacks Equity Research

NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and solid recurring revenue base.

Ecolab's AdvaCare Disinfectant Receives First EPA Approval

by Zacks Equity Research

Ecolab's (ECL) AdvaCare Disinfectant receives first EPA approval for a laundry disinfectant and oxidizer emerging viral pathogen claim that is effective against the coronavirus.

Sanghamitra Saha headshot

4 Sector ETFs & Stocks to Buy on Record Jobs Gain in May

by Sanghamitra Saha

The U.S. jobs report for the month of May reflected the largest one-month job gains.